Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin

Date
2021
Author
Benvenuti, Pietro
Zanotti, Roberta
Bonadonna, Patrizia
Scaffidi, Luigi
Doubek, Michael
Elberink, Hanneke Oude
Span, Lambert F. R.
Hermine, Olivier
Elena, Chiara
Güçlü, Yavuz Selim
Brockow, Knut
Zink, Alexander
Aberer, Elisabeth
Gorska, Aleksandra
Romantowski, Jan
Hadzijusufovic, Emir
Fortina, Anna Belloni
Caroppo, Francesca
Perkins, Cecelia
Illerhaus, Anja
Panse, Jens
Vucinic, Vladan
Jawhar, Mohamad
Sabato, Vito
Triggiani, Massimo
Parente, Roberta
Bergstrom, Anna
Breynaert, Christine
Gotlib, Jason
Reiter, Andreas
Hartmann, Karin
Niedoszytko, Marek
Arock, Michel
Kluin-Nelemans, Hanneke C.
Sperr, Wolfgang R.
Greul, Rosemarie
Valent, Peter
Fuchs, David
Kilbertus, Alex
Kofler, Karin
von Bubnoff, Nikolas
Shoumariyeh, Khalid
Metadata
Show full item record
Abstract
BACKGROUND: Mastocytosis in adults often presents with skin lesions. A bone marrow biopsy is necessary to confirm or exclude the presence of systemic mastocytosis (SM) in these cases. When a bone marrow biopsy is not performed, the provisional diagnosis is mastocytosis in the skin (MIS). No generally accepted scoring system has been established to estimate the risk of SM in these patients.
URI
http://hdl.handle.net/20.500.12627/170842
https://doi.org/10.1016/j.jaip.2020.12.022
Collections